PAVmed Inc. Series Z Warrant (PAVMZ)
$0.00
$0.00
(-40.00%)
As on 30-Apr-2025 16:00EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
10 Years Aggregate
CFO
$-220.04 Mln
EBITDA
$-282.86 Mln
Net Profit
$-301.27 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
PAVmed Inc. Series Z Warrant (PAVMZ)
| -90.9 | -83.9 | -91.3 | -96.4 | -89.1 | -75.8 | -- |
|
BSE Sensex*
| -11.7 | -4.8 | 1.1 | -8.2 | 3.9 | 5.1 | 10.0 |
|
Company
|
2024
|
2023
|
|---|---|---|
|
PAVmed Inc. Series Z Warrant (PAVMZ)
| -90.8 | -50.0 |
|
BSE Sensex
| 8.1 | 18.7 |
|
BSE Sensex
| 8.1 | 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout PAVmed Inc. Series Z Warrant (PAVMZ)
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for... use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York Read more
-
Chairman & CEO
Dr. Lishan Aklog M.D.
-
Chairman & CEO
Dr. Lishan Aklog M.D.
-
Headquarters
New York, NY
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for PAVmed Inc. Series Z Warrant (PAVMZ)
What is the current share price of PAVmed Inc Series Z Warrant (PAVMZ) Today?
The share price of PAVmed Inc Series Z Warrant (PAVMZ) is $0.00 (NASDAQ) as of 30-Apr-2025 16:00 EDT. PAVmed Inc Series Z Warrant (PAVMZ) has given a return of -89.06% in the last 3 years.
What is the current PB & PE ratio of PAVmed Inc Series Z Warrant (PAVMZ)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2024 |
0.00 |
0.00 |
2023 |
-0.01 |
-0.02 |
2022 |
-0.01 |
-0.14 |
2021 |
-2.74 |
2.24 |
2020 |
-0.12 |
2.16 |
What is the 52 Week High and Low of PAVmed Inc Series Z Warrant (PAVMZ)?
The 52-week high and low of PAVmed Inc Series Z Warrant (PAVMZ) are Rs -- and Rs -- as of 14-Sep-2026.
What is the market cap of PAVmed Inc Series Z Warrant (PAVMZ)?
PAVmed Inc Series Z Warrant (PAVMZ) has a market capitalisation of -- as on 30-Apr-2025. As per SEBI classification, it is a company.
Should I invest in PAVmed Inc Series Z Warrant (PAVMZ)?
Before investing in PAVmed Inc Series Z Warrant (PAVMZ), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.